
https://www.science.org/content/blog-post/break-whether-i-felt-it-or-not
# A Break, Whether I Felt Like It Or Not (February 2007)

## 1. SUMMARY

This is a personal reflection piece by a pharmaceutical industry researcher who has just become unemployed for the first time since the late 1980s. He recounts his early career struggles, including difficulty finding work after his postdoc in West Germany, where his job applications went unanswered until he returned to the US. The author expresses feeling disconnected from his normal research workflow without access to SciFinder and online journal subscriptions, and reflects on his last lab activity from November 2006 involving what he describes as testing "weird research ideas." He expresses hope that this forced break will actually be productive, believing it will generate fresh perspectives rather than causing him to go "rusty," and notes his dislike for the constrained focus on single projects that characterized graduate school.

## 2. HISTORY

The author appears to be Derek Lowe, who has been writing the "In the Pipeline" blog about drug discovery and the pharmaceutical industry since the early 2000s, first on the Science magazine website and later independently. His blogging career continued and expanded significantly after this period. Lowe has become one of the most widely read and respected voices in pharmaceutical industry commentary, known for his candid analysis of drug discovery challenges, clinical trial failures, and industry trends. His blog served as an important platform for discussing scientific and business realities of drug development with minimal hype. The pharmaceutical industry during 2007-2010 faced significant challenges including patent cliffs for major drugs, increasing R&D costs, and declining productivity in drug discovery pipelines across many companies. Many researchers experienced layoffs during this period as companies restructured R&D operations. The subsequent years saw continued consolidation in the pharmaceutical industry, with numerous mergers and acquisitions, while the biotech sector experienced cycles of growth and contraction. Research tools and databases like SciFinder continued to be essential but expensive resources, though open-access publishing gained momentum during this period.

## 3. PREDICTIONS

• **Prediction about career break productivity**: The author speculated that his forced break would generate "interesting stuff built up and ready to go" rather than causing him to "go rusty." **Outcome**: This appears to have been accurate - Lowe continued and expanded his influential writing career, suggesting the break did indeed provide creative energy and perspective that fueled his subsequent work.

• **Implicit prediction about research approach**: The author expressed his dislike for "constant, forced attention on one single project and problem" and hoped the break would "do him good." **Outcome**: The shift away from traditional corporate research constraints toward independent commentary and analysis aligns well with his expressed preference for broader, less constrained intellectual exploration.

## 4. INTEREST

Rating: **3/10**

This is primarily a personal career reflection with minimal direct relevance to biotechnology developments or scientific analysis. While it provides some insight into the human side of pharmaceutical industry employment during a challenging period, it lacks substantive discussion of biotech science, drug development, or policy. The interest value is limited to understanding the career trajectory of a notable industry commentator.


----
_model_params = {'model': 'nex-agi/deepseek-v3.1-nex-n1:free', 'input': '20070205-break-whether-i-felt-it-or-not.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_